CAR T細胞療法の世界市場

• 英文タイトル:Global Market Study on CAR T-cell Therapy: The Future of Cancer Treatment

Global Market Study on CAR T-cell Therapy: The Future of Cancer Treatment「CAR T細胞療法の世界市場」(市場規模、市場予測)調査レポートです。• レポートコード:PMR-DC011
• 出版社/出版日:Persistence Market Research / 2019年11月24日
• レポート形態:英文、PDF、150ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Individual User(1名用)¥529,200 (USD4,900)▷ お問い合わせ
  Multi User(5名用)¥820,800 (USD7,600)▷ お問い合わせ
  Corporate User(企業用)¥1,144,800 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査レポートでは、CAR T細胞療法の世界市場について調査・分析し、市場概要、成功要因、需要分析、市場背景、製品別(イエスカルタ、キムリア、JCAR017)分析、疾患別(再発型大細胞型B細胞リンパ腫、急性リンパ芽球性白血病(ALL)、多発性骨髄腫)分析、エンドユーザー別(病院、がん治療センター)分析、価格別(プレミアム、ミッドレンジ、ローレンジ)分析、地域別(北米、ヨーロッパ、日本)分析、市場構造分析、競合分析などを含め次の構成でお届け致します。

・エグゼクティブサマリー
・市場概要
・成功要因
・需要分析
・市場背景
・CAR T細胞療法の世界市場:製品別(イエスカルタ、キムリア、JCAR017)
・CAR T細胞療法の世界市場:疾患別(再発型大細胞型B細胞リンパ腫、急性リンパ芽球性白血病(ALL)、多発性骨髄腫)
・CAR T細胞療法の世界市場:エンドユーザー別(病院、がん治療センター)
・CAR T細胞療法の世界市場:価格別(プレミアム、ミッドレンジ、ローレンジ)
・CAR T細胞療法の世界市場:地域別(北米、ヨーロッパ、日本)
・市場構造分析
・競合分析

CAR T-Cell Therapy Market – Scope of the Report

Persistence Market Research (PMR) recently published a market study on the global market for CAR T-cell therapy. The study provides detailed assessment on the key market dynamics, including drivers, trends, opportunities restraints, and detailed information about the CAR T-cell therapy market structure. The market study presents exclusive information about how the CAR T-cell therapy market will grow during the forecast period 2019 – 2026.

Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market, and compounded annual growth rate (CAGR) are explained in PMR’s study in a comprehensive manner. This information can help readers understand the quantitative growth prospects of the CAR T-cell therapy market during the forecast period.

The study is relevant for stakeholders in the CAR T-cell therapy market, including CAR T-cell therapy products manufactures, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Stakeholders in the CAR T-cell therapy market, investors, industry experts, researchers, and journalists, as well as business researchers can leverage the information and data presented in PMR’s study.

The study also includes statistics as well as facts related to macroeconomic factors that are impacting developments in the market. It also offers actionable insights based on the future trends in the CAR T-cell therapy market. Furthermore, small businesses and new entrants in the CAR T-cell therapy market too can make use of the information presented in this study, based on, which they can make appropriate business decisions to gain momentum in the CAR T-cell therapy market.

Key Questions Answered in PMR’s CAR T-Cell Therapy Market Report

Which regions will continue to remain the most profitable regional markets for CAR T-cell therapy market players?
Which factors will essentially induce a change in the demand for CAR T-cell therapy in the forecast period?
How will changing trends impact the CAR T-cell therapy market?
What are key manufacturers’ strategy to enhance their product adoption and improve regional product footprints?
Which companies are leading the CAR T-cell therapy market?
What are the winning strategies of stakeholders in the CAR T-cell therapy market to upscale their position in this landscape?
CAR T-Cell Therapy Market: Research Methodology

In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the CAR T-cell therapy market, and reach conclusions on future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of conclusions.

Secondary resources referred to analysts during the production of the CAR T-cell therapy market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as a validation from companies in the CAR T-cell therapy market, and makes PMR’s projection on the growth prospects of the CAR T-Cell therapy market more accurate and reliable.

レポート目次

1. Executive Summary

1.1. Global Market Outlook

1.2. Key Market Trends

1.3. Market Share Analysis, By Taxonomy

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Key Success Factors

3.1. Iceberg Analysis

3.2. Revenue Opportunity Analysis

3.3. Parent Market Analysis

3.4. Pipeline Assessment

3.5. Potential Population Eligible for CAR T-cell Therapy, By Region

3.6. List of Authorized Treatment Centers in the U.S. & U.K.

3.7. Key Inclusion & Exclusion

4. Global CAR T-Cell Therapy Market Demand (in Value or Size in US$ Mn) Analysis 2017–2018 and Forecast, 2019–2026

4.1. Historical Market Value (US$ Mn) Analysis, 2017–2018

4.2. Current and Future Market Value (US$ Mn) Projections, 2019–2026

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Market Background

5.1. Macro-Economic Factors

5.1.1. Increase in Healthcare Spending

5.1.2. Emergence of Academia as the Primary Organization for Carrying Out Research

5.1.3. Collaborative Efforts and Initiatives to Identify Therapies for Difficult-To-Treat Illnesses

5.2. Forecast Factors – Relevance & Impact

5.2.1. Increasing Availability of CAR T-cell Therapy

5.2.2. Increasing Adoption of CAR T-cell Therapy

5.2.3. Superior Product Efficacy

5.2.4. Improving Reimbursement Scenario

5.2.5. Collaboration among Pharmaceutical and Biopharmaceutical Companies

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunity Analysis

6. Global CAR T-Cell Therapy Market Analysis 2017–2018 and Forecast 2019–2026, by Product Type

6.1. Introduction / Key Findings

6.2. Historical Market Size (US$ Mn) and Analysis By Product Type, 2017–2018

6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019–2026

6.3.1. Yescarta (axicabtagene ciloleucel)

6.3.2. Kymriah (tisagenlecleucel)

6.3.3. JCAR017 (lisocabtagene maraleucel)

6.3.4. bb2121 Market Attractiveness Analysis By Product Type

7. Global CAR T-Cell Therapy Market Analysis 2017–2018 and Forecast 2019–2026, by Indication

7.1. Introduction / Key Findings

7.2. Historical Market Size (US$ Mn) Analysis By Indication, 2017–2018

7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2019–2026

7.3.1. Relapsed Large B-cell Lymphoma

7.3.2. Acute Lymphoblastic Leukemia (ALL)

7.3.3. Multiple Myeloma

7.4. Market Attractiveness Analysis By Indication

8. Global CAR T-Cell Therapy Market Analysis 2017–2018 and Forecast 2019–2026, by End User

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By End User, 2017–2018

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2019–2026

8.3.1. Hospitals

8.3.2. Cancer Treatment Centers

8.4. Market Attractiveness Analysis By End User

9. Global CAR T-Cell Therapy Market Analysis 2017–2018 and Forecast 2019–2026, by Region

9.1. Introduction

9.2. Historical Market Size (US$ Mn Analysis By Region, 2017–2018

9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019–2026

9.3.1. North America

9.3.2. Europe

9.3.3. Japan

9.4. Market Attractiveness Analysis By Region

10. North America CAR T-Cell Therapy Market Analysis 2017–2018 and Forecast 2019–2026

10.1. Introduction

10.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2018

10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019–2026

10.3.1. By Country

10.3.1.1. U.S.

10.3.1.2. Canada

10.3.2. By Product Type

10.3.3. By Indication

10.3.4. By End User

10.4. Market Attractiveness Analysis

10.5. Key Market Participants – Intensity Mapping

10.6. Drivers and Restraints – Impact Analysis

11. Europe CAR T-Cell Therapy Market Analysis 2017–2018 and Forecast 2019–2026

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2018

11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019–2026

11.3.1. By Country

11.3.1.1. Germany

11.3.1.2. Italy

11.3.1.3. France

11.3.1.4. U.K.

11.3.1.5. Spain

11.3.1.6. Rest of Europe

11.3.2. By Product Type

11.3.3. By Indication

11.3.4. By End User

11.4. Market Attractiveness Analysis

11.5. Key Market Participants – Intensity Mapping

11.6. Drivers and Restraints – Impact Analysis

12. Japan CAR T-Cell Therapy Market Analysis 2017–2018 and Forecast 2019–2026

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2017–2018

12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019–2026

12.3.1. By Product Type

12.3.2. By Indication

12.3.3. By End User

12.4. Market Attractiveness Analysis

12.5. Key Market Participants – Intensity Mapping

12.6. Drivers and Restraints – Impact Analysis

13. Market Structure Analysis

13.1. Market Analysis by Tier of Companies (CAR T-Cell Therapy)

13.2. Market Share Analysis of Top Players

13.3. Market Presence Analysis

13.3.1. By Regional footprint of Players

13.3.2. Treatment foot print by Players

13.3.3. Channel Foot Print by Players

14. Competition Analysis

14.1. Competition Dashboard

14.2. Pricing Analysis by Competition

14.3. Competition Benchmarking

14.4. Competition Deep Dive

14.4.1. Novartis AG

14.4.1.1. Overview

14.4.1.2. Drug Portfolio

14.4.1.3. Profitability by Market Segments (Drug/Channel/Region)

14.4.1.4. Sales Footprint

14.4.1.5. Strategy Overview

14.4.1.5.1. Marketing Strategy

14.4.1.5.2. Drug Strategy

14.4.1.5.3. Channel Strategy

14.4.2. Gilead Sciences Inc.

14.4.2.1. Overview

14.4.2.2. Drug Portfolio

14.4.2.3. Profitability by Market Segments (Drug/Channel/Region)

14.4.2.4. Sales Footprint

14.4.2.5. Strategy Overview

14.4.2.5.1. Marketing Strategy

14.4.2.5.2. Drug Strategy

14.4.2.5.3. Channel Strategy

14.4.3. Celgene Corporation

14.4.3.1. Overview

14.4.3.2. Drug Portfolio

14.4.3.3. Profitability by Market Segments (Drug/Channel/Region)

14.4.3.4. Sales Footprint

14.4.3.5. Strategy Overview

14.4.3.5.1. Marketing Strategy

14.4.3.5.2. Drug Strategy

14.4.3.5.3. Channel Strategy

14.4.4. bluebird bio, Inc.

14.4.4.1. Overview

14.4.4.2. Drug Portfolio

14.4.4.3. Profitability by Market Segments (Drug/Channel/Region)

14.4.4.4. Sales Footprint

14.4.4.5. Strategy Overview

14.4.4.5.1. Marketing Strategy

14.4.4.5.2. Drug Strategy

14.4.4.5.3. Channel Strategy

15. Assumptions and Acronyms Used

16. Research Methodology

List of Tables

Table 01: CAR T-Cell Therapy, Pipeline Assessment

Table 02: CAR T-Cell Therapy, Pipeline Assessment

Table 03: CAR T-Cell Therapy, Pipeline Assessment

Table 04: CAR T-Cell Therapy, Pipeline Assessment

Table 05: CAR T-Cell Therapy, Pipeline Assessment

Table 06: CAR T-Cell Therapy, Pipeline Assessment

Table 07: CAR T-Cell Therapy, Pipeline Assessment

Table 08: CAR T-Cell Therapy, Pipeline Assessment

Table 09: CAR T-Cell Therapy, Pipeline Assessment

Table 10: CAR T-Cell Therapy, Pipeline Assessment

Table 11: CAR T-Cell Therapy, Pipeline Assessment

Table 12: CAR T-Cell Therapy, Pipeline Assessment

Table 13: CAR T-Cell Therapy, Pipeline Assessment

Table 14: CAR T-Cell Therapy, Pipeline Assessment

Table 15: CAR T-Cell Therapy, Pipeline Assessment

Table 16: CAR T-Cell Therapy, Pipeline Assessment

Table 17: CAR T-Cell Therapy, Pipeline Assessment

Table 18: CAR T-Cell Therapy, Pipeline Assessment

Table 19: CAR T-Cell Therapy, Pipeline Assessment

Table 20: CAR T-Cell Therapy, Pipeline Assessment

Table 21: CAR T-Cell Therapy, Pipeline Assessment

Table 22: CAR T-Cell Therapy, Pipeline Assessment

Table 23: CAR T-Cell Therapy, Pipeline Assessment

Table 24: CAR T-Cell Therapy, Pipeline Assessment

Table 25: CAR T-Cell Therapy, Pipeline Assessment

Table 26: CAR T-Cell Therapy, Pipeline Assessment

Table 27: Treatment Centers Authorized to Administer CAR T-Cell Therapy in the U.S.

Table 28: Treatment Centers Authorized to Administer CAR T-Cell Therapy in the U.S.

Table 29: Treatment Centers Authorized to Administer CAR T-Cell Therapy in the U.S.

Table 30: Treatment Centers Authorized to Administer CAR T-Cell Therapy in the U.S.

Table 31: Treatment Centers Authorized to Administer CAR T-Cell Therapy in the U.K.

Table 32: Global CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Product Type

Table 33: Global CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Indication

Table 34: Global CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By End User

Table 35: Global CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Region

Table 36: North America CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Country

Table 37: North America CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Product Type

Table 38: North America CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Indication

Table 39: North America CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By End User

Table 40: Europe CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Country

Table 41: Europe CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Product Type

Table 42: Europe CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Indication

Table 43: Europe CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By End User

Table 44: Japan CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Product Type

Table 45: Japan CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By Indication

Table 46: Japan CAR T-Cell Therapy Market Size (US$ Mn) Analysis 2017-2018 and Forecast 2019-2026, By End User


• 英文レポート名:Global Market Study on CAR T-cell Therapy: The Future of Cancer Treatment
• 日本語訳:CAR T細胞療法の世界市場
• レポートコード:PMR-DC011お問い合わせ(見積依頼・ご注文・質問)